Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | Y009341 | OT |
No additional AE reported.; report T/E for ROTATEQ that was administered. T/E date was on 2/18/2025 and ROTATEQ was administered on 2/27/2025; This spontaneous report was received from a nurse concerning to a patient of unspecified age and gender. The patient's medical history, concurrent conditions, concomitant therapies, and drug reactions/allergies were not reported. On 18-Feb-2025, doses of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) underwent a temperature excursion at a temperature of 32.0 degrees Fahrenheit (F) during a timeframe of 2 hours, 12 minutes and 0 seconds without previous temperature excursions. On 27-Feb-2025, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), lot #Y009341, expiration date 24-Nov-2025), dose number 1, 1 dosage form administered by Oral route (po) as prophylaxis (product storage error.) No additional adverse events were reported (no adverse event.)